{
  "id": 28140,
  "title": "J&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B",
  "url": "https://urgent.news/2026/07/30/j-j-nabs-option-to-buy-in-vivo-car-t-maker-sail-for-nearly-2-6b",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-30T15:52:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/johnson-johnson-sail-option-acquire-in-vivo-car-t/826589/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The deal with the buzzy Flagship Pioneering-backed startup makes J&J the latest large drugmaker to bet that the technology might be able to treat autoimmune conditions.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}